Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws
Robert Nathenson () and
Michael R. Richards ()
Additional contact information
Robert Nathenson: University of Pennsylvania
Michael R. Richards: Vanderbilt University School of Medicine
International Journal of Health Economics and Management, 2018, vol. 18, issue 3, 321-336
Abstract Direct-to-consumer advertising (DTCA) for prescription drugs is a relatively unique feature of the US health care system and a source of tens of billions of dollars in annual spending. It has also garnered the attention of researchers and policymakers interested in its implications for firm and consumer behavior. However, few economic studies have explored the DTCA response to public policies, especially those mandating coverage of these products. We use detailed advertising expenditure data to assess if pharmaceutical firms increase their marketing efforts after the implementation of relevant state and federal health insurance laws. We focus on mental health parity statutes and related drug therapies—a potentially ripe setting for inducing stronger consumer demand. We find no clear indication that firms expect greater value from DTCA after these regulatory changes. DTCA appears driven by other considerations (e.g., product debut); however, it remains a possibility that firms respond to these laws through other, unobserved channels (e.g., provider detailing).
Keywords: Mental health parity; Pharmaceutical advertising; Insurance regulation; Direct-to-consumer advertising (search for similar items in EconPapers)
JEL-codes: I11 I13 I18 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
http://link.springer.com/10.1007/s10754-018-9234-3 Abstract (text/html)
Access to full text is restricted to subscribers.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:kap:ijhcfe:v:18:y:2018:i:3:d:10.1007_s10754-018-9234-3
Ordering information: This journal article can be ordered from
http://www.springer. ... th/journal/10754/PS2
Access Statistics for this article
International Journal of Health Economics and Management is currently edited by Leemore Dafny, Robert Town, Mark Pauly, David Dranove and Pedro Pita Barros
More articles in International Journal of Health Economics and Management from Springer
Bibliographic data for series maintained by Sonal Shukla ().